Standard-dose intradermal influenza vaccine elicits cellular immune responses similar to those of intramuscular vaccine in men with and those without hiv infection

Samuel Amoah, Margarita Mishina, Prabda Praphasiri, Weiping Cao, Jin Hyang Kim, Justine S. Liepkalns, Zhu Guo, Paul J. Carney, Jessie C. Chang, Stefan Fernandez, Shikha Garg, Lauren Beacham, Timothy H. Holtz, Marcel E. Curlin, Fatimah Dawood, Sonja J. Olsen, Shivaprakash Gangappa, James Stevens, Suryaprakash Sambhara

Research output: Contribution to journalArticle

Abstract

Background: Human immunodeficiency virus (HIV)-infected persons are at a higher risk of severe influenza. Although we have shown that a standard-dose intradermal influenza vaccine versus a standard-dose intramuscular influenza vaccine does not result in differences in hemagglutination-inhibition titers in this population, a comprehensive examination of cell-mediated immune responses remains lacking. Methods: Serological, antigen-specific B-cell, and interleukin 2-, interferon γ-, and tumor necrosis factor α-secreting T-cell responses were assessed in 79 HIV-infected men and 79 HIV-uninfected men. Results: The route of vaccination did not affect the immunoglobulin A and immunoglobulin G (IgG) plasmablast or memory B-cell response, although these were severely impaired in the group with a CD4+ T-cell count of <200 cells/μL. The frequencies of IgG memory B cells measured on day 28 after vaccination were highest in the HIV-uninfected group, followed by the group with a CD4+ T-cell count of ≥200 cells/μL and the group with a CD4+ T-cell count of <200 cells/μL. The route of vaccination did not affect the CD4+ or CD8+ T-cell responses measured at various times after vaccination. Conclusions: The route of vaccination had no effect on antibody responses, antibody avidity, T-cell responses, or B-cell responses in HIV-infected or HIV-uninfected subjects. With the serological and cellular immune responses to influenza vaccination being impaired in HIV-infected individuals with a CD4+ T-cell count of <200 cells/μL, passive immunization strategies need to be explored to protect this population. Clinical trials registration: NCT01538940.

Original languageEnglish (US)
Pages (from-to)743-751
Number of pages9
JournalJournal of Infectious Diseases
Volume220
Issue number5
DOIs
StatePublished - Jul 31 2019

Keywords

  • Cell-mediated
  • Hiv
  • Influenza
  • Intradermal
  • Intramuscular
  • Vaccination

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Standard-dose intradermal influenza vaccine elicits cellular immune responses similar to those of intramuscular vaccine in men with and those without hiv infection'. Together they form a unique fingerprint.

  • Cite this

    Amoah, S., Mishina, M., Praphasiri, P., Cao, W., Kim, J. H., Liepkalns, J. S., Guo, Z., Carney, P. J., Chang, J. C., Fernandez, S., Garg, S., Beacham, L., Holtz, T. H., Curlin, M. E., Dawood, F., Olsen, S. J., Gangappa, S., Stevens, J., & Sambhara, S. (2019). Standard-dose intradermal influenza vaccine elicits cellular immune responses similar to those of intramuscular vaccine in men with and those without hiv infection. Journal of Infectious Diseases, 220(5), 743-751. https://doi.org/10.1093/infdis/jiz205